Clinical Trial Update: Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin [Phase 3]

View source ↗

Summary

A Phase 3 study of liraglutide in people with type 2 diabetes who use insulin was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Victoza (Liraglutide)

Snippet

Sponsor: University of Manitoba | Conditions: Type 2 Diabetes | Phase 3 | Status: TERMINATED